Table 2.
Blood pressure and laboratory characteristics in control and treatment group at randomization and at the end of the study.
| At randomization | End of the study | |||||
|---|---|---|---|---|---|---|
| Enalapril group | Control group | P values | Enalapril group | Control group | P values | |
| Systolic BP (mm Hg) | 163 ± 3.1 | 164 ± 2.9 | n.s. | 144 ± 4.3 | 148 ± 5.1 | n.s. |
| Diastolic BP (mm Hg) | 82 ± 3.0 | 84 ± 2.7 | n.s. | 83 ± 4 | 81 ± 2.5 | n.s. |
| Proteinuria mg/24 H |
1010 ± 153 | 1021 ± 140 | n.s. | 1085 ± 162 | 1092 ± 168 | n.s. |
| Serum albumin (gr/dL) | 3.4 ± 0.7 | 3.5 ± 0.6 | n.s. | 3.60 ± 0.55 | 3.73 ± 0.62 | n.s. |
| Hemoglobin (gr/dL) | 11.2 ± 1.1 | 10.9 ± 1.4 | n.s. | 11.9 ± 0.45 | 11.7 ± 0.38 | n.s. |
| Serum potassium (mEq/L) | 3.9 ± 0.3 | 4.0 ± 0.1 | n.s. | 4.1 ± 0.5 | 4.2 ± 0.4 | n.s. |
| Serum calcium (mg/dL) | 8.1 ± 0.9 | 7.9 ± 1.0 | n.s. | 8.5 ± 1.3 | 8.6 ± 1.6 | n.s. |
| Serum Phosphate (mg/dL) | 5.1 ± 1.4 | 5.4 ± 1.5 | n.s. | 4.7 ± 0.90 | 4.9 ± 0.85 | n.s. |
| C reactive protein (mg/dL) | 0.92 ± 0.9 | 1.0 ± 0.96 | n.s. | 1.2 ± 1.1 | 2.4 ± 0.98 | P < 0.01 |